• AAPL 195.495
  • TSLA 243.3814
  • AMZN 147.195
  • BTC-USD 43815.7148
  • ETH-USD 2348.1094
  • EURUSD 1.076
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. RVNC.US

Revance The (RVNC NASDAQ) stock market data APIs

$7.04 -0.05(-0.7%) as of December 7, 2023

Revance The Financial Data Overview

7.09
7.04
-
7.2
6.93
5.72-37.98
623 M
87 814 K
214 M
-1.63
0
0.828
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RVNC',
Type: 'Common Stock',
Name: 'Revance The',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001J2MJH8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1479290',
EmployerIdNumber: '77-0551645',
FiscalYearEnd: 'December',
IPODate: '2014-02-06',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
GicSector: 'Health Care',
GicGroup: 'Pharmaceuticals, Biotechnology & Life Sciences',
GicIndustry: 'Pharmaceuticals',
GicSubIndustry: 'Pharmaceuticals',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Revance The Fundamental Data is available in our Financial Data APIs

  • Net Revenue 214 M
  • EBITDA -213 612 000
  • Earnings Per Share -5.1
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Revance The Earnings via APIs

  • Latest Release 2023-11-08
  • EPS/Forecast -0.85

Get Revance The End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Revance The latest news via APIs

Analysts Just Slashed Their Revance Therapeutics, Inc. (NASDAQ:RVNC) EPS Numbers

One thing we could say about the analysts on Revance Therapeutics, Inc. (NASDAQ:RVNC) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript November 8, 2023 Revance Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.63 EPS, expectations were $-...
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com